Fabrinet
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-89.9% vs price
Base Case (Median)
-80.5% vs price
Bull Case (75th pct.)
-76.0% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $29.22 | -95.0% | High (40%) |
| PE Comparable | $291.85 | -49.9% | Medium (25%) |
| Growth Trajectory DCF | $159.29 | -72.6% | Medium (20%) |
| Graham Number | $120.05 | -79.4% | Low (10%) |
| EV/EBITDA | $113.45 | -80.5% | Medium (20%) |
| EV/FCF | $25.31 | -95.7% | Medium (20%) |
| Earnings Power Value | $88.77 | -84.8% | Medium (50%) |
Based on 7 out of 8 methods, FN appears overvalued at the current price of $582.24. The base case fair value of $113.45 implies 80.5% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.